Nuts can help control colon cancer

The addition of some nuts from almonds, pecans, chestnuts and cashews can significantly reduce the risk of "re-exporting" of colon cancer cells.

This is a new study published before the upcoming conference on cancer in Chicago (USA) next month.

The team of researchers conducted a study with 826 patients undergoing treatment for stage III colon cancer, often undergoing both surgery and chemotherapy.

This group of patients has a 70% chance to live 3 years after treatment because the disease is in the stage of non-metastasis in the body. About 19% of these patients received at least 56g extra hard shell nuts in a week.

The results showed that, in this group, the risk of recurrent cancer cells decreased by 42%, while the risk of death also decreased by 57% compared to patients who did not eat the nuts after the end of treatment process. cancer.

This is the first time scientists have tested the effects of nuts on colon and rectal cancers.

Particularly for patients who ate only seeds from trees, (excluding underground seeds) at least 56g / week, the results showed that the risk of cancer cells recurring decreased by 46%. muscle death decreased by 53% compared to people who did not eat.

There have been many studies showing the benefits of adding nuts to the daily menu for the treatment of cardiovascular and diabetic diseases, but this is the first time scientists have validated the effect. Uses of nuts for colon and rectal cancers.

Therefore, this study is considered to be an important contribution to the design of the menu and workout schedule so that cancer patients reduce the risk of relapse and die after treatment.

However, scientists note that adding these nuts to the daily menu cannot replace the main treatments such as chemotherapy for colon cancer.

In addition, patients should incorporate factors such as keeping optimistic, healthy eating.

In addition, another report published at the same time showed that following a Chinese diet and maintaining exercise could also reduce the risk of recurrence and death in colon cancer patients.